I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 23% ± 3% | |
| glutamatergic neuron | 3 studies | 31% ± 6% | |
| oligodendrocyte | 3 studies | 18% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 23% ± 3% | |
| glutamatergic neuron | 3 studies | 31% ± 6% | |
| oligodendrocyte | 3 studies | 18% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 468.27 | 2641 / 2642 | 100% | 6.83 | 704 / 705 |
| prostate | 100% | 424.67 | 245 / 245 | 100% | 4.53 | 501 / 502 |
| thymus | 100% | 835.43 | 653 / 653 | 99% | 8.05 | 600 / 605 |
| breast | 100% | 270.21 | 457 / 459 | 97% | 5.36 | 1089 / 1118 |
| ovary | 99% | 217.93 | 178 / 180 | 95% | 3.86 | 410 / 430 |
| adrenal gland | 99% | 222.74 | 255 / 258 | 93% | 3.07 | 213 / 230 |
| kidney | 100% | 275.61 | 89 / 89 | 84% | 2.43 | 760 / 901 |
| bladder | 100% | 363.38 | 21 / 21 | 77% | 4.38 | 386 / 504 |
| pancreas | 99% | 198.65 | 324 / 328 | 72% | 1.98 | 128 / 178 |
| lung | 100% | 399.44 | 577 / 578 | 67% | 2.98 | 777 / 1155 |
| uterus | 100% | 250.95 | 170 / 170 | 53% | 2.78 | 244 / 459 |
| liver | 94% | 209.39 | 212 / 226 | 59% | 1.77 | 238 / 406 |
| stomach | 100% | 240.21 | 358 / 359 | 52% | 1.19 | 150 / 286 |
| intestine | 100% | 261.23 | 965 / 966 | 45% | 1.02 | 235 / 527 |
| skin | 100% | 334.75 | 1802 / 1809 | 38% | 0.89 | 179 / 472 |
| esophagus | 100% | 275.02 | 1444 / 1445 | 37% | 1.33 | 68 / 183 |
| spleen | 100% | 442.67 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.73 | 1 / 1 |
| adipose | 99% | 198.89 | 1195 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 225.81 | 1319 / 1335 | 0% | 0 | 0 / 0 |
| heart | 97% | 254.14 | 837 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 2.79 | 26 / 29 |
| muscle | 47% | 52.61 | 376 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 33% | 0.77 | 15 / 45 |
| peripheral blood | 28% | 101.90 | 263 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 14% | 0.20 | 11 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF682 |
| Protein name | BC39498_2 (Zinc finger protein 682, isoform CRA_b) Zinc finger protein 682 ZNF682 protein (Zinc finger protein 682) |
| Synonyms | hCG_36741 |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | ENST00000597972.5 M0QXB8 M0R067 ENST00000593468.5 O95780 ENST00000358523.9 [O95780-3] ENST00000595736.1 [O95780-2] ENST00000397162.5 [O95780-3] ENST00000601100.5 ENST00000602079.5 ENST00000397165.7 [O95780-1] O95779 ENST00000595534.1 B9EG95 ENST00000594127.5 M0R2B6 ENST00000596019.5 M0QZ56 M0R1A6 M0QYJ5 |
